Till 2030, the entire world should be driven by Indian quality standards, regulatory processes, and manufacturing practices, he said at the International Conference on Pharmaceuticals and Medical organised by industry body Ficci.
Coining a new acronym, he said the world today needs CURE — Cost-effective Universal solutions through Research and Enterprise. “If we take it upon ourselves that India is going to cure the world, I see no limitations in our ability to aspire to become a world dominant leader in the field of medtech, pharmaceuticals, medical devices, and health care providers.”
The country would always be indebted to the Indian pharma industry, often called the pharmacy of the world, for its contribution in fighting the Covid-19 pandemic, Goyal said. The three Vs that the industry has provided to the world, and to India — ventilators, vaccines, and the V-shaped recovery in India’s economy — are reflective of the industry’s strength.
WTO waiver for easy vaccine access
Goyal said India’s proposal at the World Trade Organization (WTO) for trade-related aspects of intellectual property rights waiver to allow more countries to get equitable access to Covid-19 vaccine is getting support from other nations. India along with South Africa had introduced a proposal in October 2020 for waiving the intellectual property rights regime so that more countries get equitable access to medicines, Goyal said.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in